Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name: Pazopanib Hcl
Latin Name: Unii-33Y9anm545
CAS NO: 635702-64-6
MF: C21H23N7O2S.ClH
MW: 473.987
EINECS NO; 619-728-0
Pazopanib hydrochloride is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. Pazopanib hydrochloride is a multi-targeted tyrosine kinase inhibitor that inhibits angiogenesis for advanced renal cell carcinoma (RCC).
Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
1. Customs clearance